GlassScriptPhysician profile
Jaclyn Jankowski
NPI 1225491483
$32,853.49
in general payments reported to CMS, 2019-2025
28 companies · $14K in 2025
The $14K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,313 · 2022: $1,837 · 2023: $636 · 2024: $14K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $12K · Food and Beverage: $4,668 · Consulting Fee: $4,650 · Education: $3,675 · Travel and Lodging: $3,461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $12,250.00 |
| Food and Beverage | $4,667.69 |
| Consulting Fee | $4,650.00 |
| Education | $3,675.00 |
| Travel and Lodging | $3,460.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $19,788.37 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Synthes USA Products LLC | $5,759.12 | 2024 | |
| Arthrex, INC. | $1,880.44 | 2021 | |
| Depuy Synthes Sales INC. | $1,588.37 | 2022-2025 | Na, Va-Lcp, Reclaim |
| Stryker Corporation | $1,248.95 | 2022-2025 | Mako, Insignia, Gamma |
| Zimmer Biomet Holdings, INC. | $490.10 | 2022-2025 | Comprehensive Shoulder System |
| Nuvasive Specialized Orthopedics, INC. | $327.55 | 2022-2023 | Precice Intramedullary Limb Lengthening System |
| Smith+Nephew, INC. | $306.67 | 2021-2022 | |
| Ethicon US, LLC | $283.58 | 2024-2025 | Vistaseal, Surgicel Nu-Knit, Stratafix |
| Acera Surgical, INC. | $221.76 | 2024 | Restrata Wound Matrix |
| Pylant Medical | $181.92 | 2021 | |
| Si-Bone, INC. | $121.88 | 2022 | |
| Medacta USA, INC. | $113.61 | 2023-2024 | Gmk Efficiency |
| Medtronic, INC. | $101.61 | 2021-2023 | Aquamantys(Tm) |
| Heron Therapeutics, INC. | $98.07 | 2021-2023 | Zynrelef |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $55.89 | 2022 | |
| Ferring Pharmaceuticals INC. | $42.05 | 2024 | Euflexxa |
| Royal Biologics, INC. | $38.55 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $34.36 | 2025 | |
| Conmed Corporation | $26.41 | 2024 | Airseal |
| Polynovo North America LLC | $24.36 | 2024 | Novosorb Btm |
| Bioventus LLC | $20.44 | 2025 | Durolane |
| Sanara Medtech INC. | $19.41 | 2024 | Celleraterx |
| Dynasplint Systems INC. | $19.26 | 2024 | Dynasplint |
| Sanofi-Aventis U.S. LLC | $16.77 | 2022 | |
| Next Science LLC | $16.33 | 2022 | |
| Orthofix Medical, INC. | $15.59 | 2024 | Physio-Stim |
| Pacira Pharmaceuticals Incorporated | $12.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaclyn Jankowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.